Literature DB >> 3349886

Effect of glucagon on vagally induced gastric acid secretion in humans.

F B Loud1, J J Holst, J Christiansen, J F Rehfeld.   

Abstract

The effect of a physiologically relevant dose of pancreatic glucagon, 85 pmol/kg/hr, or saline on gastric acid secretion induced by modified sham feeding (chew and spit), was studied in 10 healthy volunteers. Gastric pH was held constant (pH 5.5) by intragastric titration. Glucagon infusion inhibited gastric acid secretion significantly, from 19.6 +/- 1.5 mmol H+ per hour during saline, to 10.4 +/- 1.4 mmol H+ per hour. Blood glucose increased during glucagon infusion and remained constant during saline infusion. Serum gastrin concentrations increased significantly by sham feeding, during saline as well as glucagon infusion, and no difference between the gastrin response during saline or glucagon infusion was found. Thus glucagon, in a physiologic dose, reduces vagally mediated acid secretion by a gastrin-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349886     DOI: 10.1007/bf01536022

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  The effect of gastrin on basal and aminoacid-stimulated insulin and glucagon secretion in man.

Authors:  J F Rehfeld; J J Holst; C Kühl
Journal:  Eur J Clin Invest       Date:  1978-02       Impact factor: 4.686

2.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

Authors:  W A Müller; G R Faloona; E Aguilar-Parada; R H Unger
Journal:  N Engl J Med       Date:  1970-07-16       Impact factor: 91.245

3.  Inhibition of pentagastrin-induced gastric acid secretion in man by glucagon given intravenously.

Authors:  G Dotevall; N G Kock; A Walan
Journal:  Scand J Gastroenterol       Date:  1969       Impact factor: 2.423

4.  Peptide secretory pathways in GI tract: cytochemical contributions to regulatory physiology of the gut.

Authors:  L I Larsson
Journal:  Am J Physiol       Date:  1980-10

5.  Is glucagon present in the human gastric fundus?

Authors:  S Ito; T Iwanaga; Y Kusumoto; N Sudo; M Sano; T Suzuki; A Shibata
Journal:  Horm Metab Res       Date:  1981-08       Impact factor: 2.936

6.  Effect of glucagon on meal-induced gastric secretion in man.

Authors:  S J Konturek; J Biernat; N Kwiecień; J Oleksy
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

7.  Inhibition of gastric acid secretion in humans by glucagon during euglycemia, hyperglycemia, and hypoglycemia.

Authors:  F B Loud; J J Holst; J F Rehfeld; J Christiansen
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

8.  Is somatostatin a humoral regulator of the endocrine pancreas and gastric acid secretion in man?

Authors:  F B Loud; J J Holst; E Egense; B Petersen; J Christiansen
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

9.  Nervous control of gastro-pancreatic somatostatin secretion in pigs.

Authors:  J J Holst; C Sottimano; M Olesen; S Lindkaer; O V Nielsen
Journal:  Peptides       Date:  1981       Impact factor: 3.750

10.  Effects of glucagon and histamine on human parietal cells.

Authors:  W Schepp; H J Ruoff; H J Dein; S Miederer
Journal:  Agents Actions       Date:  1986-04
View more
  2 in total

Review 1.  Glucagon-like peptide-1, a new hormone of the entero-insular axis.

Authors:  C Orskov
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

2.  Effects of intravenous infusion of glucose and pancreatic glucagon on abomasal function in dairy cows.

Authors:  K Holtenius; S O Jacobsson; P Holtenius
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.